NTEC News and Press, Intec Pharma Ltd. From 07/22/19

JERUSALEM , July 22, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces top-line data from the Company's pivotal Phase 3 trial (the ACCORDANCE trial) evaluating the safety and efficacy of the Accordion Pill ® -Carbidopa/Levodopa (AP...

Gainers:  Immuron (NASDAQ: IMRN ) +81% . Blue Apron Holdings (NYSE: APRN ) +49% . Moxian (NASDAQ: MOXC ) +35% . GAIN Capital Holdings (NYSE: GCAP ) +32% . Lonestar Resources (NASDAQ: LONE ) +19% . AVROBIO (NASDAQ: AVRO ) +17% . Dolphin Entertainment (NASDAQ: DLPN ) +16% . Bio-P...

Horizons ETFs Rebalances Marijuana-Focused ETFs Canada NewsWire TORONTO, July 3, 2019 TORONTO , July 3, 2019 /CNW/ - Horizons ETFs Management ( Canada ) Inc. (" Horizons ETFs ") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana L...

JERUSALEM , July 1, 2019 /PRNewswire/ --   Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced that a review highlighting the benefits of the Accordion Pill ® (AP) oral drug delivery platform was published in the peer-reviewed journal, Therapeutic ...

Results from an open-label two-way crossover Phase 2 clinical trial evaluating Intec Pharma's (NASDAQ: NTEC ) Accordion Pill - Carbidopa/Levodopa (AP-CD/LD) in Parkinson's disease (PD) patients showed a treatment effect. The data were just published in the journal Parkinson's and Relat...

JERUSALEM , June 25, 2019 /PRNewswire/ ---  Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that results from an earlier Phase 2 clinical study of the Accordion Pill ® -Carbidopa/Levodopa (AP-CD/LD) in Parkinson's disease (PD) patients were publ...

The following slide deck was published by Intec Pharma Ltd. in conjunction with this Read more ...

JERUSALEM , June 19, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced that results from a pharmacokinetics (PK) study of the Accordion Pill™-Carbidopa/Levodopa (AP-CD/LD) 50/500 mg dosed three times per day (TID) were highlighted...

JERUSALEM , May 28, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in June.  Jefferies Global Healthcare Conference Date: June 4-7, 20...

Editor's note: Seeking Alpha is proud to welcome James Mase as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » Thesis Tetra...